<p>This is a $74,620 firm-fixed-price purchase order awarded by the Air Force Research Laboratory (AFRL) to Aigene Inc., a small business, under the SBIR Program Phase I. The contract is to optimize cancer therapy and reduce cancer costs for the Air Force. The contract has a completion date of August 7, 2023. This contract is a set-aside for small businesses.</p>
This is a $109,516 firm fixed price purchase order awarded by the Air Force Research Laboratory (AFRL) to Wayfinder Genetics, LLC, a minority-owned, small disadvantaged, veteran-owned limited liability company. The contract is for a Small Business Technology Transfer (STTR) Phase I effort titled "Rapid Detection of Infection Using Quorum Sensing Molecules". The contract has a total small business set-aside designation and a period of performance through August 12, 2024. Wayfinder...
The Department of the Air Force Materiel Command Research Laboratory awarded a $749,991 firm fixed price purchase order to Definitive Biotechnologies, LLC as part of the Small Business Innovation Research Program Phase II Action. Under this contract, Definitive Biotechnologies will deliver a disposable, multiplex molecular device for simultaneous point-of-care diagnosis of coronavirus disease 2019 and influenza. The contract has a total small business set aside designation. Performance will...
This $73,188 firm-fixed-price Phase I Small Business Innovation Research (SBIR) contract was awarded by the U.S. Air Force Research Laboratory (AFRL) to Geneinfosec Inc., a self-certified small disadvantaged business. The contract, set aside for small businesses, is for research and development of DNA-based molecular cryptography techniques to enhance data security and network defense capabilities. This award builds upon Geneinfosec's previous SBIR Phase I and Phase II contracts with AFRL...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to B-Mogen Biotechnologies Inc. for the development of "NEXT GENERATION GENOME EDITING TOOLS." The contract is a firm-fixed-price definitive contract with a ceiling value of $149,431.43 and a period of performance ending on April 20, 2018. As an SBIR Phase I award, this contract is focused on the research and development of innovative technologies that...
This is a $1,249,833 SBIR Phase II contract awarded by the Air Force Research Laboratory (AFRL) to Othram Inc., a self-certified small disadvantaged business. The contract is for enabling forensic intelligence through genome-wide analysis of forensic DNA evidence. Othram specializes in forensic and investigative genetic genealogy services for federal government agencies, providing advanced DNA testing, genome sequencing, genealogy research, evidence digitization, and expert witness support for...
This is a firm-fixed-price purchase order awarded by the Air Force Research Laboratory (AFRL) to Charlot Biosciences Inc., a minority-owned, self-certified small disadvantaged business. The $49,869 contract is for the SBIR (Small Business Innovation Research) Program Phase I development of a system for rapid pathogen threat detection in aerial and field environments. The award is set aside for small businesses. Charlot Biosciences Inc. has received multiple SBIR awards from the Department of the...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Health Agency (DHA) to Firebird Biomolecular Sciences LLC, a for-profit limited liability company, for the development of "Innovative DNA for Highly Multiplexed Molecular Diagnostics". The $249,956.88 firm-fixed-price contract has a period of performance ending on May 8, 2025. The contract supports research and development of novel molecular technologies to create a rapid, point-of-sampling...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI) to Myriad RBM, Inc. for the development of a clinical automated multiplex affinity capture technology to detect low abundance cancer-related proteins and peptides. The contract has a firm fixed price of $1,126,627.00 and was awarded on September 28, 2007, with a scheduled completion date of June 27, 2010. As an SBIR Phase I contract, this award represents the initial research and...
<p>This is a $299,999.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Innogenomics Technologies, L.L.C., a minority-owned small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for research and development in the area of biomedical (basic research). It was awarded on September 22, 2015 with a final completion date of March 21, 2017. The contract has a total small business set-aside designation.</p>